NO20024590D0 - Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation - Google Patents
Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparationInfo
- Publication number
- NO20024590D0 NO20024590D0 NO20024590A NO20024590A NO20024590D0 NO 20024590 D0 NO20024590 D0 NO 20024590D0 NO 20024590 A NO20024590 A NO 20024590A NO 20024590 A NO20024590 A NO 20024590A NO 20024590 D0 NO20024590 D0 NO 20024590D0
- Authority
- NO
- Norway
- Prior art keywords
- oligosaccharides
- preparation
- pharmaceutical preparations
- new
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Materials Engineering (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003910A FR2807043B1 (en) | 2000-03-28 | 2000-03-28 | PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION |
PCT/FR2001/000903 WO2001072762A1 (en) | 2000-03-28 | 2001-03-26 | Pharmaceutical compositions containing oligosaccharides and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20024590L NO20024590L (en) | 2002-09-25 |
NO20024590D0 true NO20024590D0 (en) | 2002-09-25 |
Family
ID=8848572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024590A NO20024590D0 (en) | 2000-03-28 | 2002-09-25 | Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1272499B1 (en) |
JP (1) | JP2003529570A (en) |
KR (1) | KR20030001394A (en) |
CN (1) | CN1183149C (en) |
AR (1) | AR034251A1 (en) |
AT (1) | ATE290543T1 (en) |
AU (1) | AU782713B2 (en) |
BR (1) | BR0109617A (en) |
CA (1) | CA2403906A1 (en) |
DE (1) | DE60109279T2 (en) |
EA (1) | EA004768B1 (en) |
EE (1) | EE200200551A (en) |
ES (1) | ES2236206T3 (en) |
FR (1) | FR2807043B1 (en) |
HK (1) | HK1056564A1 (en) |
HU (1) | HUP0300330A3 (en) |
IL (1) | IL151832A0 (en) |
ME (1) | MEP88408A (en) |
MX (1) | MXPA02009455A (en) |
NO (1) | NO20024590D0 (en) |
NZ (1) | NZ521558A (en) |
PL (1) | PL204419B1 (en) |
PT (1) | PT1272499E (en) |
SK (1) | SK286745B6 (en) |
WO (1) | WO2001072762A1 (en) |
YU (1) | YU72802A (en) |
ZA (1) | ZA200207707B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6750207B1 (en) * | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
FR2845686B1 (en) * | 2002-10-10 | 2013-08-30 | Aventis Pharma Sa | MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US7511026B2 (en) * | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
FR2857971B1 (en) * | 2003-07-24 | 2005-08-26 | Aventis Pharma Sa | MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US20050186679A1 (en) * | 2004-02-24 | 2005-08-25 | Christian Viskov | Method for determining specific groups constituting heparins or low molecular weight heparins |
JP5116071B2 (en) | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | Use of anti-neuropathic pain effects of D-allose and D-psicose |
US8211899B2 (en) | 2005-08-30 | 2012-07-03 | Inter-University Research Institute Corporation National Institute Of Natural Sciences | Artificial nucleic acid bases and their use in base pairing natural nucleic acid bases |
EP3418287A1 (en) * | 2017-06-21 | 2018-12-26 | Universität für Bodenkultur Wien | Chemical release of asparaginelinked glycans |
CN115317507A (en) * | 2022-09-19 | 2022-11-11 | 中国科学院海洋研究所 | Application of low molecular weight fucoidan in preparation of anti-hyperactivity drugs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
-
2000
- 2000-03-28 FR FR0003910A patent/FR2807043B1/en not_active Expired - Fee Related
-
2001
- 2001-03-26 DE DE60109279T patent/DE60109279T2/en not_active Expired - Fee Related
- 2001-03-26 IL IL15183201A patent/IL151832A0/en unknown
- 2001-03-26 ES ES01919561T patent/ES2236206T3/en not_active Expired - Lifetime
- 2001-03-26 BR BR0109617-6A patent/BR0109617A/en not_active IP Right Cessation
- 2001-03-26 EE EEP200200551A patent/EE200200551A/en unknown
- 2001-03-26 CN CNB018084087A patent/CN1183149C/en not_active Expired - Fee Related
- 2001-03-26 EP EP01919561A patent/EP1272499B1/en not_active Expired - Lifetime
- 2001-03-26 PL PL357301A patent/PL204419B1/en unknown
- 2001-03-26 EA EA200201024A patent/EA004768B1/en not_active IP Right Cessation
- 2001-03-26 HU HU0300330A patent/HUP0300330A3/en unknown
- 2001-03-26 CA CA002403906A patent/CA2403906A1/en not_active Abandoned
- 2001-03-26 KR KR1020027012867A patent/KR20030001394A/en not_active Application Discontinuation
- 2001-03-26 AU AU46639/01A patent/AU782713B2/en not_active Ceased
- 2001-03-26 MX MXPA02009455A patent/MXPA02009455A/en active IP Right Grant
- 2001-03-26 SK SK1393-2002A patent/SK286745B6/en not_active IP Right Cessation
- 2001-03-26 JP JP2001570671A patent/JP2003529570A/en active Pending
- 2001-03-26 ME MEP-884/08A patent/MEP88408A/en unknown
- 2001-03-26 AT AT01919561T patent/ATE290543T1/en not_active IP Right Cessation
- 2001-03-26 WO PCT/FR2001/000903 patent/WO2001072762A1/en not_active Application Discontinuation
- 2001-03-26 YU YU72802A patent/YU72802A/en unknown
- 2001-03-26 PT PT01919561T patent/PT1272499E/en unknown
- 2001-03-26 NZ NZ521558A patent/NZ521558A/en not_active IP Right Cessation
- 2001-03-27 AR ARP010101456A patent/AR034251A1/en unknown
-
2002
- 2002-09-25 NO NO20024590A patent/NO20024590D0/en unknown
- 2002-09-25 ZA ZA200207707A patent/ZA200207707B/en unknown
-
2003
- 2003-11-26 HK HK03108634A patent/HK1056564A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032187D0 (en) | Heterocyclylalkylpiperidine derivatives, their preparation and preparations containing the compounds | |
NO982580D0 (en) | New taxoids, their preparation and pharmaceutical preparations containing the taxoids | |
NO20024176L (en) | Pharmaceutical preparations contain derivatives of 3-amino-azetidine, the new derivatives and their preparation | |
NO20024175D0 (en) | Acetidine derivatives, their preparation and pharmaceutical compounds containing the same | |
NO20010013L (en) | Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation and use as well as pharmaceutical preparations containing the compounds | |
NO20032438D0 (en) | Ortho and Metasubstituted Bis-Aryl Compounds, Their Preparation and Use, and Pharmaceutical Preparations Containing the Compounds | |
NL1015859A1 (en) | Pharmaceutical preparations. | |
NO20030296D0 (en) | Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions | |
NO20005146L (en) | Thienylazolylalkoxyethanamines, their preparation and their use as drugs | |
NO992102L (en) | Peptide composition, as well as pharmaceutical composition and cancer vaccine including the peptide composition | |
NO20023400L (en) | New compounds with hypolidemic and hypocholesterolemic effect, their preparation and preparations containing the compounds | |
DK1098874T3 (en) | Benzocycloheptenes, Methods of Preparation, Pharmaceutical Preparations Containing Them, and Their Use in the Preparation of Drugs | |
NO20022021D0 (en) | Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, the preparation of the same and their use as anorexic drugs | |
NO995745D0 (en) | New Derivatives of Erythromycin, Methods of Preparation thereof, and Their Use as Medicines | |
NO20016247L (en) | Streptogramin derivatives, their preparation and preparations containing the derivatives | |
NO20041773L (en) | Pharmaceutical preparations for reducing cell activity and their use. | |
NO20003661D0 (en) | New pentasaccharides, methods for their preparation and pharmaceutical preparations containing the same | |
NO20024590D0 (en) | Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation | |
DK1118610T3 (en) | Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing the derivatives | |
NO983472D0 (en) | Taxoids, their preparation and pharmaceutical preparations containing the taxoids | |
PT1228039E (en) | N-GUANIDINOALQUILAMIDES ITS PREPARATION ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME | |
NO20035163D0 (en) | New piperidinecarboxamide derivatives, processes for their preparation and pharmaceutical preparations containing the same | |
DK199900435U3 (en) | Pharmaceutical preparation comprising paroxetine methanesulfonate and use thereof | |
NO20014692D0 (en) | 3-amidinobenzenesulfonamide derivatives, medical compositions containing them and intermediates in the preparation thereof | |
NO985171D0 (en) | Sulfonamide-substituted fused 5-ring compounds, their use as a medicament, and pharmaceutical preparations containing the compounds |